Synthesis and evaluation of in vitro anti-tuberculosis activity of N-substituted glycolamides

被引:10
作者
Duyaee, Fereidoon [2 ,3 ]
Kobarfard, Farzad [1 ]
Khalaj, Ali [4 ]
Farnia, Parisa [5 ]
机构
[1] Shaheed Beheshti Univ Med Sci, Fac Pharm, Dept Med Chem, Tehran, Iran
[2] Kerman Univ Med Sci, Dept Med Chem, Fac Pharm, Kerman, Iran
[3] Kerman Univ Med Sci, Neurosci Res Ctr, Kerman, Iran
[4] Univ Tehran Med Sci, Fac Pharm, Dept Med Chem, Tehran, Iran
[5] Shaheed Beheshti Univ Med Sci, Natl Res Inst TB & Lung Dis, Tehran, Iran
关键词
Anti-tuberculosis; Glycolamide; Alamar blue assay; N-Glycolyl muramic acid; Cell wall; MYCOBACTERIUM-TUBERCULOSIS; INHIBITORS;
D O I
10.1016/j.ejmech.2008.02.022
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
On the basis of the structural similarity of N-substituted glycolamides with N-glycolyl muramic acid residues of the cell wall of Mycobacterium tuberculosis, a series of these compounds were designed and synthesized by the reaction of glycolic acid acetonide 1 (2,2-dimethyl-5-oxo-1,3-dioxolane) with the proper amines. The minimum inhibitory concentration (MIC) was determined against M. tuberculosis H(37)Rv in BACTEC 12B medium, using the Microplate Alamar Blue Assay (MABA). Among the synthesized compounds, all those with disubstituted amide structure accompanied by one or two heteroatom(s) with loan pair(s) of electrons atom(s) P to the amide nitrogen demonstrated moderate anti-tuberculosis activity and all the monosubstituted amides showed no activity at all. (C) 2008 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:289 / 295
页数:7
相关论文
共 14 条
[1]  
BARROWS TH, 1985, Patent No. 4529792
[2]  
BERSA GS, 1997, J PHARM PHARMACOL, V49, P25
[3]   Microplate Alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium [J].
Collins, LA ;
Franzblau, SG .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (05) :1004-1009
[4]  
DARYAEE F, 2006, DARU, V13, P94
[5]  
De Cock KM, 1999, INT J TUBERC LUNG D, V3, P457
[6]  
Ellner J. J., 2001, Tuberculosis, V81, P1
[7]  
FISCHER A, 1957, Patent No. 3883509
[8]   Tuberculosis [J].
Frieden, TR ;
Sterling, TR ;
Munsiff, SS ;
Watt, CJ ;
Dye, C .
LANCET, 2003, 362 (9387) :887-899
[9]   Drug targeting Mycobacterium tuberculosis cell wall synthesis:: Genetics of dTDP-rhamnose synthetic enzymes and development of a microtiter plate-based screen for inhibitors of conversion of dTDP-glucose to dTDP-rhamnose [J].
Ma, YF ;
Stern, RJ ;
Scherman, MS ;
Vissa, VD ;
Yan, WX ;
Jones, VC ;
Zhang, FQ ;
Franzblau, SG ;
Lewis, WH ;
McNeil, MR .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (05) :1407-1416
[10]   ALPHA-HYDROXY AMIDES AND RELATED COMPOUNDS [J].
SHAPIRO, SL ;
ROSE, IM ;
FREEDMAN, L .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1959, 81 (23) :6322-6329